Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 56.52 percent increase over losses of $(0.23) per share from the same period last year.
Loup Sees ‘Land Grab’ Among Food Delivery Companies: What Investors Should Know
If you’ve ordered food delivery, chances are you’ve seen different prices than what the restaurants charge in the physical locations. You also may have seen several promotions incentivizing you to place your order.
